Study S000206

Feasibility of Semaglutide Therapy for Weight Loss in Advanced Lung Disease: A Pilot Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05746039
Study type: INTERVENTIONAL
Phase: PHASE1; PHASE2
Masking: NONE
Status: RECRUITING
Enrollment: 8
Start: 2024-01-29
Primary completion: 2027-12-28
Lead sponsor: University of Pennsylvania
Conditions: Obesity; Interstitial Lung Disease; Chronic Obstructive Pulmonary Disease; Sarcoidosis, Pulmonary; Pulmonary Hypertension
Interventions: DRUG:Semaglutide Pen Injector
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Tolerability [12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.